Suzetrigine

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
It is the perfect drug for knee scope, dental, breast aug, acute on chronic pain.

If the class proves out and they have successor drugs, we will be out of the schedule 2 business in 10 years.

Trulilicity was fda approved in 2014 and look at where tirzepatide is and what retatrutide is likely to be.
 
there will be a lot of surgeons who use this drug. interventional spine docs will want to write for something for acute radiculopathy.

the market for this drug for postsurgical pain is huge.



(we will never not be asked about schedule 2 drugs)
 
Bringing this back- anyone prescribing this medication for pain for short term (14 days) when patient calls for increased pain?

Seems like an okay thing to try for acute on chronic pain rather than opiates
 

Members do not see ads. Register today.

Haven't found one patient that thinks it helps with anything
 
Top Bottom